• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类癌症中突变特征的地形。

Topography of mutational signatures in human cancer.

机构信息

Department of Cellular and Molecular Medicine, UC San Diego, La Jolla, CA 92093, USA; Department of Bioengineering, UC San Diego, La Jolla, CA 92093, USA; Moores Cancer Center, UC San Diego, La Jolla, CA 92037, USA; Department of Health Informatics, Graduate School of Informatics, Middle East Technical University, Ankara 06800, Turkey.

Department of Cellular and Molecular Medicine, UC San Diego, La Jolla, CA 92093, USA; Department of Bioengineering, UC San Diego, La Jolla, CA 92093, USA; Moores Cancer Center, UC San Diego, La Jolla, CA 92037, USA.

出版信息

Cell Rep. 2023 Aug 29;42(8):112930. doi: 10.1016/j.celrep.2023.112930. Epub 2023 Aug 4.

DOI:10.1016/j.celrep.2023.112930
PMID:37540596
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10507738/
Abstract

The somatic mutations found in a cancer genome are imprinted by different mutational processes. Each process exhibits a characteristic mutational signature, which can be affected by the genome architecture. However, the interplay between mutational signatures and topographical genomic features has not been extensively explored. Here, we integrate mutations from 5,120 whole-genome-sequenced tumors from 40 cancer types with 516 topographical features from ENCODE to evaluate the effect of nucleosome occupancy, histone modifications, CTCF binding, replication timing, and transcription/replication strand asymmetries on the cancer-specific accumulation of mutations from distinct mutagenic processes. Most mutational signatures are affected by topographical features, with signatures of related etiologies being similarly affected. Certain signatures exhibit periodic behaviors or cancer-type-specific enrichments/depletions near topographical features, revealing further information about the processes that imprinted them. Our findings, disseminated via the COSMIC (Catalog of Somatic Mutations in Cancer) signatures database, provide a comprehensive online resource for exploring the interactions between mutational signatures and topographical features across human cancer.

摘要

在癌症基因组中发现的体细胞突变是由不同的突变过程所留下的印记。每个过程都表现出独特的突变特征,这些特征可能受到基因组结构的影响。然而,突变特征与拓扑基因组特征之间的相互作用尚未得到广泛探索。在这里,我们整合了来自 40 种癌症类型的 5120 个全基因组测序肿瘤和 ENCODE 的 516 个拓扑特征中的突变,以评估核小体占有率、组蛋白修饰、CTCF 结合、复制时间和转录/复制链不对称性对不同致突变过程中癌症特异性突变积累的影响。大多数突变特征受到拓扑特征的影响,具有相关病因的特征受到类似的影响。某些特征在拓扑特征附近表现出周期性行为或癌症类型特异性的富集/缺失,揭示了更多关于印记它们的过程的信息。我们的发现通过 COSMIC(癌症体细胞突变目录)特征数据库进行了传播,为探索人类癌症中突变特征与拓扑特征之间的相互作用提供了一个全面的在线资源。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b2a/10507738/e8f889dfa1f3/nihms-1928262-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b2a/10507738/7be43c6d8a0c/nihms-1928262-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b2a/10507738/54f6a200fc34/nihms-1928262-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b2a/10507738/91b96b06abc6/nihms-1928262-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b2a/10507738/0a81199e4683/nihms-1928262-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b2a/10507738/8d621b14543c/nihms-1928262-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b2a/10507738/e612ab91e424/nihms-1928262-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b2a/10507738/e8f889dfa1f3/nihms-1928262-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b2a/10507738/7be43c6d8a0c/nihms-1928262-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b2a/10507738/54f6a200fc34/nihms-1928262-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b2a/10507738/91b96b06abc6/nihms-1928262-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b2a/10507738/0a81199e4683/nihms-1928262-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b2a/10507738/8d621b14543c/nihms-1928262-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b2a/10507738/e612ab91e424/nihms-1928262-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b2a/10507738/e8f889dfa1f3/nihms-1928262-f0008.jpg

相似文献

1
Topography of mutational signatures in human cancer.人类癌症中突变特征的地形。
Cell Rep. 2023 Aug 29;42(8):112930. doi: 10.1016/j.celrep.2023.112930. Epub 2023 Aug 4.
2
Impact of cancer mutational signatures on transcription factor motifs in the human genome.癌症突变特征对人类基因组转录因子基序的影响。
BMC Med Genomics. 2019 May 20;12(1):64. doi: 10.1186/s12920-019-0525-4.
3
Evaluating topography of mutational signatures with SigProfilerTopography.使用SigProfilerTopography评估突变特征的拓扑结构。
bioRxiv. 2024 Jan 9:2024.01.08.574683. doi: 10.1101/2024.01.08.574683.
4
The repertoire of mutational signatures in human cancer.人类癌症中的突变特征谱。
Nature. 2020 Feb;578(7793):94-101. doi: 10.1038/s41586-020-1943-3. Epub 2020 Feb 5.
5
An overview of mutational and copy number signatures in human cancer.人类癌症中突变和拷贝数特征概述。
J Pathol. 2022 Jul;257(4):454-465. doi: 10.1002/path.5912. Epub 2022 May 20.
6
Cancer Mutational Processes Vary in Their Association with Replication Timing and Chromatin Accessibility.癌症突变过程在与复制时间和染色质可及性的关联上存在差异。
Cancer Res. 2021 Dec 15;81(24):6106-6116. doi: 10.1158/0008-5472.CAN-21-2039. Epub 2021 Oct 26.
7
Clinical and genomic characterization of mutational signatures across human cancers.人类癌症中突变特征的临床和基因组特征。
Int J Cancer. 2023 Apr 15;152(8):1613-1629. doi: 10.1002/ijc.34402. Epub 2023 Jan 6.
8
Mutational Signatures in Cancer (MuSiCa): a web application to implement mutational signatures analysis in cancer samples.癌症突变特征(MuSiCa):一个用于在癌症样本中实施突变特征分析的网络应用程序。
BMC Bioinformatics. 2018 Jun 14;19(1):224. doi: 10.1186/s12859-018-2234-y.
9
Mutational spectra and mutational signatures: Insights into cancer aetiology and mechanisms of DNA damage and repair.突变图谱和突变特征:深入了解癌症的病因以及 DNA 损伤和修复的机制。
DNA Repair (Amst). 2018 Nov;71:6-11. doi: 10.1016/j.dnarep.2018.08.003. Epub 2018 Aug 24.
10
Patterns and processes of somatic mutations in nine major cancers.九大常见癌症中的体细胞突变模式和过程。
BMC Med Genomics. 2014 Feb 19;7:11. doi: 10.1186/1755-8794-7-11.

引用本文的文献

1
Intraline genomic heterogeneity of the triple-negative breast cancer MDA-MB-231-luc-GFP cell line.三阴性乳腺癌MDA-MB-231-luc-GFP细胞系的细胞内基因组异质性。
Comput Struct Biotechnol J. 2025 Jun 27;27:2871-2880. doi: 10.1016/j.csbj.2025.06.033. eCollection 2025.
2
Clinical syndromes linked to biallelic germline variants in MCM8 and MCM9.与MCM8和MCM9双等位基因种系变异相关的临床综合征。
HGG Adv. 2025 Jul 18;6(4):100480. doi: 10.1016/j.xhgg.2025.100480.
3
Identification and Validation of a Previously Missed Mutational Signature in Colorectal Cancer.

本文引用的文献

1
Uncovering novel mutational signatures by extraction with SigProfilerExtractor.通过SigProfilerExtractor提取来揭示新的突变特征。
Cell Genom. 2022 Nov 9;2(11):None. doi: 10.1016/j.xgen.2022.100179.
2
Mechanisms of APOBEC3 mutagenesis in human cancer cells.APOBEC3 在人类癌细胞中致突变的机制。
Nature. 2022 Jul;607(7920):799-807. doi: 10.1038/s41586-022-04972-y. Epub 2022 Jul 20.
3
APOBEC3 mutational signatures are associated with extensive and diverse genomic instability across multiple tumour types.APOBEC3 突变特征与多种肿瘤类型中广泛而多样的基因组不稳定性相关。
结直肠癌中一种先前被遗漏的突变特征的鉴定与验证
bioRxiv. 2025 Jun 7:2025.06.06.658321. doi: 10.1101/2025.06.06.658321.
4
The mutagenic forces shaping the genomes of lung cancer in never smokers.塑造非吸烟者肺癌基因组的诱变力量。
Nature. 2025 Jul 2. doi: 10.1038/s41586-025-09219-0.
5
Evaluating topography of mutational signatures with SigProfilerTopography.使用SigProfilerTopography评估突变特征的图谱。
Genome Biol. 2025 May 20;26(1):134. doi: 10.1186/s13059-025-03612-8.
6
Deciphering lung adenocarcinoma evolution and the role of LINE-1 retrotransposition.解析肺腺癌的演变及LINE-1逆转录转座的作用。
bioRxiv. 2025 Mar 16:2025.03.14.643063. doi: 10.1101/2025.03.14.643063.
7
Polyguanine microsatellites are robust replication clocks in cancer.聚鸟嘌呤微卫星是癌症中强大的复制时钟。
Nat Genet. 2025 Mar;57(3):489-491. doi: 10.1038/s41588-025-02098-1.
8
Deaminase-Driven Reverse Transcription Mutagenesis in Oncogenesis: Critical Analysis of Transcriptional Strand Asymmetries of Single Base Substitution Signatures.脱氨酶驱动的逆转录诱变在肿瘤发生中的作用:单碱基替换特征转录链不对称性的批判性分析
Int J Mol Sci. 2025 Jan 24;26(3):989. doi: 10.3390/ijms26030989.
9
Contributing factors to the oxidation-induced mutational landscape in human cells.人类细胞中氧化诱导突变图谱的促成因素。
Nat Commun. 2024 Dec 23;15(1):10722. doi: 10.1038/s41467-024-55497-z.
10
Computational investigation of missense somatic mutations in cancer and potential links to pH-dependence and proteostasis.计算研究癌症中的错义体细胞突变及其与 pH 依赖性和蛋白质平衡的潜在联系。
PLoS One. 2024 Nov 19;19(11):e0314022. doi: 10.1371/journal.pone.0314022. eCollection 2024.
BMC Biol. 2022 May 21;20(1):117. doi: 10.1186/s12915-022-01316-0.
4
Examining clustered somatic mutations with SigProfilerClusters.使用 SigProfilerClusters 检测聚集性体细胞突变
Bioinformatics. 2022 Jun 27;38(13):3470-3473. doi: 10.1093/bioinformatics/btac335.
5
Mapping clustered mutations in cancer reveals APOBEC3 mutagenesis of ecDNA.绘制癌症中聚集的突变图谱揭示了 ecDNA 的 APOBEC3 诱变作用。
Nature. 2022 Feb;602(7897):510-517. doi: 10.1038/s41586-022-04398-6. Epub 2022 Feb 9.
6
Mutational signatures in esophageal squamous cell carcinoma from eight countries with varying incidence.来自八个发病率不同国家的食管鳞癌中的突变特征。
Nat Genet. 2021 Nov;53(11):1553-1563. doi: 10.1038/s41588-021-00928-6. Epub 2021 Oct 18.
7
Genomic and evolutionary classification of lung cancer in never smokers.非吸烟人群肺癌的基因组和进化分类。
Nat Genet. 2021 Sep;53(9):1348-1359. doi: 10.1038/s41588-021-00920-0. Epub 2021 Sep 6.
8
Histone H3K4me1 and H3K27ac play roles in nucleosome eviction and eRNA transcription, respectively, at enhancers.组蛋白 H3K4me1 和 H3K27ac 在增强子处分别发挥核小体驱逐和 eRNA 转录的作用。
FASEB J. 2021 Aug;35(8):e21781. doi: 10.1096/fj.202100488R.
9
Learning mutational signatures and their multidimensional genomic properties with TensorSignatures.使用 TensorSignatures 学习突变特征及其多维基因组特性。
Nat Commun. 2021 Jun 15;12(1):3628. doi: 10.1038/s41467-021-23551-9.
10
H3K27me3-rich genomic regions can function as silencers to repress gene expression via chromatin interactions.富含 H3K27me3 的基因组区域可以通过染色质相互作用作为抑制子发挥作用,从而抑制基因表达。
Nat Commun. 2021 Jan 29;12(1):719. doi: 10.1038/s41467-021-20940-y.